TipRanks
Go Ultimate55% OFF

PT Siloam International Hospitals Tbk Reg-S (2LS) Stock Statistics & Valuation Metrics

Total Valuation

PT Siloam International Hospitals Tbk Reg-S has a market cap or net worth of EUR 1.20B. The enterprise value is EUR 1.48B.

Market Cap
EUR 1.20B
Enterprise Value
EUR 1.48B

Share Statistics

PT Siloam International Hospitals Tbk Reg-S has 13,006,125,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
13,006,125,000
Owned by Insiders
―
Owned by Institutions
<0.01%

Financial Efficiency

PT Siloam International Hospitals Tbk Reg-S’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)
―
Return on Assets (ROA)
―
Return on Invested Capital (ROIC)
―
Return on Capital Employed (ROCE)
―
Revenue Per Employee
―
Profits Per Employee
6.38M
Employee Count
13,461
Asset Turnover
―
Inventory Turnover
―

Income Statement

In the last 12 months, PT Siloam International Hospitals Tbk Reg-S had revenue of ― and earned 85.90B in profits. Earnings per share was ―.

Revenue
―
Gross Profit
1.52T
Operating Income
291.61B
Pretax Income
―
Net Income
85.90B
EBITDA
308.46B
Earnings Per Share (EPS)
―

Stock Price Statistics

Beta
0.30
52-Week Price Change
-18.27%
50-Day Moving Average
0.09
200-Day Moving Average
0.11
Relative Strength Index (RSI)
42.42
Average Volume (3m)
3,244

Important Dates

PT Siloam International Hospitals Tbk Reg-S upcoming earnings date is Mar 30, 2027, TBA (Not Confirmed).

Last Earnings Date
Oct 23, 2026
Next Earnings Date
Mar 30, 2027
Ex-Dividend Date
―

Balance Sheet

PT Siloam International Hospitals Tbk Reg-S has ― in cash and marketable securities with EUR 1.38T in debt, giving a net cash position of ― billion.

Cash & Marketable Securities
―
Total Debt
EUR 1.38T
Net Cash
―
Net Cash Per Share
―
Tangible Book Value Per Share
―

Analyst Forecast

The average price target for PT Siloam International Hospitals Tbk Reg-S is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
0
Revenue Growth Forecast
-2.19%
EPS Growth Forecast
6.52%